S
ZYNE

SignatureFD’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

SignatureFD’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,000
Closed -$7K – 2747
2020
Q3 		$7K Hold
2,000
– – ﹤0.01% 1797
2020
Q2 		$7K Buy
+2,000
New +$9.46K ﹤0.01% 1714

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SignatureFD's ZYNE Position: Q4 2020 in Review

SignatureFD sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2020, closing a stake of 2,000 shares — an estimated $7K sold.

SignatureFD first reported a position in ZYNE in Q2 2020 and held it in 2 quarters. The position peaked at $7K in Q3 2020. 58 funds tracked by Wall St. Rank hold ZYNE as of Q4 2020.

  • SignatureFD reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2020 after selling out during the quarter.
  • SignatureFD sold 2,000 Zynerba Pharmaceuticals, Inc shares in Q4 2020, an estimated $7K.
  • SignatureFD first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2020 and held it in 2 quarters.
  • SignatureFD's Zynerba Pharmaceuticals, Inc position peaked at $7K in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2020.

Based on SignatureFD's 13F filing for Q4 2020, filed 11 Feb 2021.